3Arend WP, Palmer G, Gabay C. IL-1, IL 18, and IL-33 families of cytokines [J]. Immunol Rev, 2008, 223 (1): 20-38.
4Hayakawa H, Hayakama M, Kumc A, et al. Soluble ST2blocks interleukin-33 signaling in allergic airway inflammation[J]. J.Biol Chem, 2007, 282 (36): 26369- 26380.
5Kearley J, Buckland KF, Mathie SA, et al. Resolution of allergic inflammation and AHR is dependent pon disruption of The T1/ST2-IL-33 pathway [J]. Am J Respir Crit Care Med, 2009, 179 (9): 772-781.
6Park SJ, Lee YC. lnterleukin 17 regulation: an attractive therapeutic approach for asthma [J]. Respir Res, 2010, 11 (1): 78 -88.
7Nakae S, Komiyama Y, Nambu A, et al. Antigen specific T cellsensitization is impaired in 11-17 deficient mice, causing suppression of allergic cellular and humoral responses [J]. Immunity, 2002, 17 (3): 375-387.
8Smart JM, Horak E, Kemp AS, et al. Polyclonal and allergen induced cytokine response in adults with asthma: resolution of asthma is associated with normalization of IFN- gama responses[J]. J Allergy Clin Immunol, 2002, 110 (B): 450-456.
9Kirstein F, Horsnell WG, Nieuwenhuizen N, et al. Anisakis pegreffii-induced airway byperresponsiveness is mediated by gamma interferon in the absence of interleukin-4 receptor alpha responsiveness [J]. Infect lmmun, 2010, 78 (9): 4077-4086.
10Cho SH, Stanciu LA, Holgate ST, et al. Increased interleukin-4, interleukin 5, and interferon-gamma in airway CD4d- and CD81- T cells in atopic asthma [J]. Am J Respir CritCareMed, 2005, 171 (3): 224-230.
